Recent News

By Category: Research

BioDefense Therapeutics enrolls first patient for favipiravir Phase 3 clinical trials

(Bio PrepWatch) BioDefense Therapeutics said on Tuesday that its first patient for the North American Phase 3 clinical trials for favipiravir, and investigational treatment for flu, has been enrolled. Favipiravir is a new antiviral compound that selectively disrupts the virus’ replication and transcription of RNA and stops the infection cycle.

January 15, 2014
| Filed under Countermeasures and Research
Share

National lab to study virus isolated from fatal H5N1 case in Alberta

(CTVNews) Canada’s National Microbiology Laboratory has isolated live H5N1 virus from respiratory specimens taken from an Alberta woman who died recently from infection with that bird flu virus. The Winnipeg-based lab is working in collaboration with Alberta’s provincial laboratory to sequence the entire genome of the virus, which the woman is believed to have contracted Read More »

January 15, 2014
| Filed under North America, International, Public Health, and Research
Share

Moran, Jenkins Celebrate NBAF Funding In New Spending Bill

(WIBW/CNN) Senator Jerry Moran (R-KS) and Congresswoman Lynn Jenkins (KS-02) are both celebrating the inclusion of more than $400 million for the National Bio and Agro-Defense Facility (NBAF) as part of a spending bill that will fund the U.S. government through the end of the year.

January 15, 2014
| Filed under North America, Agriculture, Policy & Initiatives, and Research
Share

First Study of Promising Ebola Vaccine Undertaken In West Africa

The University of Maryland School of Medicine (UM SOM) this week announced they have begun a clinical trial in health care workers in West Africa to evaluate a promising experimental Ebola vaccine. The vaccine was developed by investigators at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID) in Read More »

January 7, 2014
| Filed under Africa, North America, Agents & Toxins, Biotechnology, International, Public Health, and Research
Share

Predicting antibiotic resistance among goals of UH research

(Eurekalert) Going back in time to compare evolutionary changes in several thousand generations of E. coli, a University of Houston (UH) biologist hopes to one day be able to isolate a bacterial pathogen and predict the likelihood it will become resistant to a particular antibiotic.